- Home
- LNN vs ARVN Comparison
LNN vs ARVN Comparison
Compare LNN & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNN
- ARVN
- Stock Information
- Founded
- LNN 1954
- ARVN 2015
- Country
- LNN United States
- ARVN United States
- Employees
- LNN N/A
- ARVN N/A
- Industry
- LNN Industrial Machinery/Components
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- LNN Industrials
- ARVN Health Care
- Exchange
- LNN Nasdaq
- ARVN Nasdaq
- Market Cap
- LNN 1.5B
- ARVN 1.4B
- IPO Year
- LNN 1988
- ARVN 2018
- Fundamental
- Price
- LNN $135.45
- ARVN $17.77
- Analyst Decision
- LNN Buy
- ARVN Strong Buy
- Analyst Count
- LNN 2
- ARVN 12
- Target Price
- LNN $136.00
- ARVN $58.82
- AVG Volume (30 Days)
- LNN 67.7K
- ARVN 1.1M
- Earning Date
- LNN 04-03-2025
- ARVN 02-11-2025
- Dividend Yield
- LNN 1.06%
- ARVN N/A
- EPS Growth
- LNN N/A
- ARVN N/A
- EPS
- LNN 6.22
- ARVN N/A
- Revenue
- LNN $611,997,000.00
- ARVN $263,399,999.00
- Revenue This Year
- LNN $10.07
- ARVN N/A
- Revenue Next Year
- LNN $3.80
- ARVN $1.63
- P/E Ratio
- LNN $21.76
- ARVN N/A
- Revenue Growth
- LNN N/A
- ARVN 235.54
- 52 Week Low
- LNN $109.27
- ARVN $16.61
- 52 Week High
- LNN $140.26
- ARVN $51.51
- Technical
- Relative Strength Index (RSI)
- LNN 56.46
- ARVN 44.33
- Support Level
- LNN $128.74
- ARVN $17.19
- Resistance Level
- LNN $139.65
- ARVN $20.38
- Average True Range (ATR)
- LNN 2.97
- ARVN 1.38
- MACD
- LNN 0.24
- ARVN 0.08
- Stochastic Oscillator
- LNN 61.50
- ARVN 30.77
About LNN Lindsay Corporation
Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.